Digital Medicine Society Launches Resources to Navigate Global Digital Health Regulatory Pathways
Resources will speed the expansion of digital health products worldwide,improving global patient access
Food
Say Hello to 3.0: Datarithm Releases Latest Version of Inventory Management Solution
SYRACUSE,N.Y.,Nov. 19,2024-- In a landscape marked by intense competition,rising costs,and stringent regulatory requirements,independent pharmacies face an array of challenges that threaten their viab
Power AI real-world monitoring ensures the safe and efficient progress of the expansion of China's longest expressway
TURFAN,China,Nov. 18,2024-- On November 15,in the transmission safety monitoring center of the State Grid Turfan Power Supply Company,the power supply personnel used the AI real-world monitoring devic
SMU Leads Singapore-Indonesia Educational Collaboration Through RI-SING University Network
SINGAPORE,Nov. 18,2024--The Singapore Management University(SMU) hosted the third RI-SING University Network (RUN) meeting on 12-13 November 2024,bringing together top educational leaders from Singap
AV-Comparatives Releases 2024 Advanced Threat Protection Test Results for Enterprise Cybersecurity Solutions
Helping CISOs Select Top-Performing Cybersecurity Solutions with Rigorous Advanced Threat Protection Testing Results for 2024
WELLlife COVID-19/Influenza A&B Home Test on Sale for Black Friday and Cyber Monday
BOLINGBROOK,Ill.,Nov. 18,2024--Stock up your family\'s medicine cabinet this Black Friday and Cyber Monday. WELLlife,a leading innovator in medical diagnostic and testing solutions,is increasing acces
Two-Day Countdown - Hong Kong Fashion Fest kicks off a city-wide celebration of fashion, culture and creativity
HONG KONG,Nov. 19,2024-- The highly anticipated Hong Kong FashionFest,running from 20 November to 4 December 2024,is set to take over the city with an expansive programme celebrating fashion,creativi
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
MELBOURNE,Australia,Nov. 19,2024-- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company) today announces it will expand its theranostic pipeline with new assets targeting Fibroblast
FinVolution Group Reports Third Quarter 2024 Unaudited Financial Results
-Third Quarter Total Transaction Volume reached RMB52.2 billion,up 1.8% year-over-year- -Third Quarter International Transaction Volume reached RMB2.7 billion,up 22.7% year-over-year-
Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at American College of Rheumatology (ACR) Conver
78-Week results from Phase III randomized controlled trial (RCT) including switching data from reference denosumab to CT-P41 (biosimilar candidate of denosumab) demonstrate comparable efficacy and sa